AKRO and NVO Related Headlines
Go Back- Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics
- Novo to buy Akero for up to $5.2 billion in new CEO's revival push
- Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion
- Morgan Stanley Reiterates Overweight Rating on Akero Therapeutics (AKRO) (premarket)

